L&G Pharma Breakthrough UCITS ETF (LON:BIGT)
1,130.61
+2.51 (0.22%)
Sep 23, 2026, 9:06 AM GMT
LON:BIGT Holdings Information
LON:BIGT is an equity ETF with a total of 46 individual holdings. The top holdings are Basilea Pharmaceutica AG stock at 2.71%, Eisai at 2.66%, Genmab at 2.63%, AstraZeneca at 2.63%, and Halozyme Therapeutics at 2.61%.
Total Holdings
46
Top 10 Percentage
26.04%
Asset Class
Equity
ETF Category
Health Care
Assets
17.11M
PE Ratio
20.10
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | SWX: BSLN | Basilea Pharmaceutica AG | 2.71% |
| 2 | TYO: 4523 | Eisai Co., Ltd. | 2.66% |
| 3 | CPH: GMAB | Genmab A/S | 2.63% |
| 4 | LON: AZN | AstraZeneca PLC | 2.63% |
| 5 | HALO | Halozyme Therapeutics, Inc. | 2.61% |
| 6 | UTHR | United Therapeutics Corporation | 2.59% |
| 7 | BIT: REC | Recordati Industria Chimica e Farmaceutica S.p.A. | 2.56% |
| 8 | AGIO | Agios Pharmaceuticals, Inc. | 2.56% |
| 9 | LGND | Ligand Pharmaceuticals Incorporated | 2.54% |
| 10 | TYO: 4516 | Nippon Shinyaku Co., Ltd. | 2.54% |
| 11 | INCY | Incyte Corporation | 2.53% |
| 12 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 2.51% |
| 13 | JNJ | Johnson & Johnson | 2.51% |
| 14 | ONC | BeOne Medicines AG | 2.51% |
| 15 | BIIB | Biogen Inc. | 2.50% |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 2.50% |
| 17 | ABUS | Arbutus Biopharma Corporation | 2.49% |
| 18 | TVTX | Travere Therapeutics, Inc. | 2.46% |
| 19 | XERS | Xeris Biopharma Holdings, Inc. | 2.46% |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 2.46% |
| 21 | ARGX | argenx SE | 2.45% |
| 22 | RIGL | Rigel Pharmaceuticals, Inc. | 2.45% |
| 23 | HKG: 9969 | InnoCare Pharma Limited | 2.45% |
| 24 | STO: SOBI | Swedish Orphan Biovitrum AB (publ) | 2.44% |
| 25 | PTCT | PTC Therapeutics, Inc. | 2.41% |
As of Sep 21, 2026